Prospective single-center study of multimodality imaging and omics data analysis to evaluate cardiac function and risk factors in breast cancer patients treated with chemothrapy
Not Applicable
Recruiting
- Conditions
- Breast cancer Drug-induced cardiomyopathy
- Registration Number
- JPRN-UMIN000038875
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who are judged irrelevant to this clinical trial by the attending doctor.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of cardiotoxicity after the treatment for breast cancer(a drop in LVEF of > 10% from baseline and < 53%). The results of omics data analysis.
- Secondary Outcome Measures
Name Time Method ncidence of symptomatic heart failure or any other cardiac event after the treatment for breast cancer.